Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017

Latest news articles

Added 10 days ago Drug news

NICE recommends Cabometyx (cabozantinib) to treat renal cell carcinoma.- Ipsen.

The National Institute for Health and Care Excellence ( NICE) has published final guidance and reversed an earlier negative decision...

Added 27 days ago Drug news

EU CHMP recommends approval of Fotivda (tivozanib) for patients with advanced renal cell carcinoma- EUSA Pharma

EUSA Pharma announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...

Added 1 month ago Drug news

Analysis confirms PFS efficacy of endpoint results of Phase II CABOSUN trial of cabozantinib versus sunitinib for renal cell carcinoma and sDNA application for first line treatment.- Exelixis Inc.

Exelixis, Inc. announced that the analysis of the review by a blinded independent radiology review committee (IRC) has confirmed the...

Search all news articles for Cancer of kidney and renal pelvis
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Breakthrough Cancer Pain Learning Zone

Invitation to watch the online broadcast of the BeCOn OWN event 'Shifting paradigms in BTcP management' on June 16 2017.

Visit Breakthrough Cancer Pain Learning Zone


Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

Visit Fluid Management


Guidelines

Guidelines on Renal Cell Carcinoma

The European Association of Urology (EAU) Renal Cell Cancer (RCC) Guidelines Panel has compiled these clinical guidelines to provide urologists...

Added 1 year ago

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best...

Added 3 years ago

Search all guidelines for Cancer of kidney and renal pelvis
 

Journal articles

Specific immunotherapy in renal cancer: a systematic review.

Renal cell cancer (RCC) is the tenth most common malignancy in adults. In recent years, several approaches of active and passive immunotherapy have been studied extensively in clinical trials of patients with RCC.

Added 3 months ago

Lenvatinib for use in combination with everolimus for the treatment of patients with advanced renal cell carcinoma following one prior anti-angiogenic therapy.

Introduction: In patients with mRCC options for second line therapies, following progression on anti-angiogenic agents, that demonstrate a survival advantage in clinical trials have been limited.

Added 3 months ago

Cabozantinib: an Active Novel Multikinase Inhibitor in Renal Cell Carcinoma.

Clear cell renal cell carcinoma (RCC) is characterized by inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene. VHL loss drives tumor angiogenesis and accounts for the clinical activity ...

Added 3 months ago

Search all journal articles for Cancer of kidney and renal pelvis
 
Fiona Holland

Fiona worked in the fitness and wellness industry in the US for 13 years, supporting behaviour change in a variety of settings. Fiona’s research interests lie broadly within health and wellbeing. She is particularly interested in qualitative methodologies in the areas of body image ... Read more

What to say and do when someone has cancer

Ahead of World Cancer Day on Saturday (February 4), Fiona Holland, Psychology Lecturer, discusses what to say and what not to say to someone with cancer.